191 related articles for article (PubMed ID: 28555645)
1. A promoter-proximal transcript targeted by genetic polymorphism controls E-cadherin silencing in human cancers.
Pisignano G; Napoli S; Magistri M; Mapelli SN; Pastori C; Di Marco S; Civenni G; Albino D; Enriquez C; Allegrini S; Mitra A; D'Ambrosio G; Mello-Grand M; Chiorino G; Garcia-Escudero R; Varani G; Carbone GM; Catapano CV
Nat Commun; 2017 May; 8():15622. PubMed ID: 28555645
[TBL] [Abstract][Full Text] [Related]
2. A functional SNP regulates E-cadherin expression by dynamically remodeling the 3D structure of a promoter-associated non-coding RNA transcript.
Sharma S; Pisignano G; Merulla J; Catapano CV; Varani G
Nucleic Acids Res; 2022 Oct; 50(19):11331-11343. PubMed ID: 36243981
[TBL] [Abstract][Full Text] [Related]
3. UHRF1 regulates CDH1 via promoter associated non-coding RNAs in prostate cancer cells.
Magnani E; Macchi F; Mancini M; Lomazzi V; Cogliati S; Pistore C; Mandruzzato M; Dock-Bregeon AC; Bonapace IM
Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):258-270. PubMed ID: 29466696
[TBL] [Abstract][Full Text] [Related]
4. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.
Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR
Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells.
Maeda G; Chiba T; Aoba T; Imai K
Odontology; 2007 Jul; 95(1):24-9. PubMed ID: 17660978
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex.
von Burstin J; Eser S; Paul MC; Seidler B; Brandl M; Messer M; von Werder A; Schmidt A; Mages J; Pagel P; Schnieke A; Schmid RM; Schneider G; Saur D
Gastroenterology; 2009 Jul; 137(1):361-71, 371.e1-5. PubMed ID: 19362090
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Int J Cancer; 2002 Aug; 100(6):683-5. PubMed ID: 12209606
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.
Li LC; Chui RM; Sasaki M; Nakajima K; Perinchery G; Au HC; Nojima D; Carroll P; Dahiya R
Cancer Res; 2000 Feb; 60(4):873-6. PubMed ID: 10706097
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.
Lindström S; Wiklund F; Jonsson BA; Adami HO; Bälter K; Brookes AJ; Xu J; Zheng SL; Isaacs WB; Adolfsson J; Grönberg H
Hum Genet; 2005 Dec; 118(3-4):339-47. PubMed ID: 16189707
[TBL] [Abstract][Full Text] [Related]
11. Targeting high transcriptional control activity of long mononucleotide A-T repeats in cancer by Argonaute 1.
Pin-On P; Aporntewan C; Siriluksana J; Bhummaphan N; Chanvorachote P; Mutirangura A
Gene; 2019 May; 699():54-61. PubMed ID: 30858133
[TBL] [Abstract][Full Text] [Related]
12. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
14. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
17. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
18. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases.
Paz MF; Wei S; Cigudosa JC; Rodriguez-Perales S; Peinado MA; Huang TH; Esteller M
Hum Mol Genet; 2003 Sep; 12(17):2209-19. PubMed ID: 12915469
[TBL] [Abstract][Full Text] [Related]
19. The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance.
Wang W; Yuasa T; Tsuchiya N; Ma Z; Maita S; Narita S; Kumazawa T; Inoue T; Tsuruta H; Horikawa Y; Saito M; Hu W; Ogawa O; Habuchi T
Int J Cancer; 2009 Dec; 125(12):2836-43. PubMed ID: 19585577
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
